MHRA consultation on statutory fees – proposals on ongoing cost recovery
Page summary:
Consultation on proposals to update the MHRA’s statutory fees to ensure they continue to recover their costs.
Change made:
Following early feedback from customers and stakeholders, we have clarified some terms in the consultation document relating to Priority 2: The MHRA proposes to amend its existing Medical Device Registration fee to include the costs for medical device post-market work. In this section we have replaced the term ‘category’ with ‘code’ and the term ‘supplier’ with ‘manufacturer’.
Time updated:
12:20pm, 10 September 2024
